[PDF] Top 20 ECT2 associated to PRICKLE1 are poor-prognosis markers in triple-negative breast cancer
Has 10000 "ECT2 associated to PRICKLE1 are poor-prognosis markers in triple-negative breast cancer" found on our website. Below are the top 20 most common "ECT2 associated to PRICKLE1 are poor-prognosis markers in triple-negative breast cancer".
ECT2 associated to PRICKLE1 are poor-prognosis markers in triple-negative breast cancer
... HAL Id: hal-02518543 https://hal.archives-ouvertes.fr/hal-02518543 Submitted on 7 Apr 2020 HAL is a multi-disciplinary open access archive for the deposit and dissemination of sci- entific research documents, whether ... Voir le document complet
31
In Vivo Assessment of VCAM-1 Expression by SPECT/CT Imaging in Mice Models of Human Triple Negative Breast Cancer
... ]. In the lungs VCAM-1 binds to α4β1 integrin expressed on macrophages triggering the activation of the PI3K/Akt survival pathway in cancer cells [ 14 ...]. In bone, VCAM-1 expressing ... Voir le document complet
14
New Insights into the Implication of Epigenetic Alterations in the EMT of Triple Negative Breast Cancer
... Abstract: Breast cancer is the most common cancer and leading cause of cancer death among women worldwide, encompassing a wide heterogeneity of subtypes with different clinical ...emerged ... Voir le document complet
22
TTK/hMPS1 is an attractive therapeutic target for triple-negative breast cancer
... Abstract Triple-negative breast cancer (TNBC) represents a subgroup of breast cancers (BC) associated with the most aggressive clinical ...TNBC. In order to ... Voir le document complet
16
Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response
... Introduction Breast cancer heterogeneity makes it difficult to bring personalized medicine into the ...disease to identify subgroups of patients with clinical significance, such as ... Voir le document complet
17
Identification of microRNA clusters cooperatively acting on epithelial to mesenchymal transition in triple negative breast cancer
... EMT in TNBC ...is associated to ap- pearance of EMT-like phenotype in the TNBC ...belonging to the cluster or the entire cluster decreases the expression of a marker of mesenchymal ... Voir le document complet
11
View of Triple Negative Breast Cancer: A review of common therapeutic Targets and Current Treatment options.
... of breast cancer that is associated with poor prognosis and is resistant to the main forms of breast cancer ...solutions to the challenges facing TNBC ... Voir le document complet
4
CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients
... shown in Figure 4, we confirmed that combination of Herceptin and Docetaxel had no significant impact on relative tumor volume (RTV) and final tumor weight in this model (Figures 4a and ...active in ... Voir le document complet
13
Plasmacytoid dendritic cells deficient in IFNα production promote the amplification of FOXP3+regulatory T cells and are associated with poor prognosis in breast cancer patients
... VIew Breast cancers are the most common malignant tumors and the first leading cause of cancer-related deaths in ...of breast carcinoma, the so-called triple negative ... Voir le document complet
4
Increased macroH2A1.1 Expression Correlates with Poor Survival of Triple-Negative Breast Cancer Patients
... generally associated with a poor outcome, which is essentially not predicted by assessment of standard clinico- pathological variables, such as lymph node status or tumour size at initial ...targets ... Voir le document complet
13
Triple-negative breast cancer : treatment challenges and solutions
... Abstract: Triple-negative breast cancers (TNBCs) are defined by the absence of estrogen and progesterone receptors and the absence of HER2 ...heterogeneous breast cancer subtype ... Voir le document complet
15
EHD2 is a Predictive Biomarker of Chemotherapy Efficacy in Triple Negative Breast Carcinoma
... localized in caveolae invaginations at the plasma ...been associated with several human cancers, however the significance of EHD2 transcript levels in cancer prognosis remains ... Voir le document complet
13
Predictive and prognostic role of peripheral blood eosinophil count in triple-negative and hormone receptor-negative/HER2-positive breast cancer patients undergoing neoadjuvant treatment
... into cancer tissue and induce normalization of the tumor vasculature ...survival. In the current study, the number of patients, the short follow-up time and the subsequent number of events registered ... Voir le document complet
15
[18F]ML-10 PET imaging fails to assess early response to neoadjuvant chemotherapy in a preclinical model of triple negative breast cancer
... exposure to chemother- ...treatment in accordance with the literature. In addition, the ex vivo analyses confirmed the increase of the apop- totic fraction at this time ...the in vivo ... Voir le document complet
15
Statistical analysis of PET radiomic features and metabolomic data: prediction of triple-negative breast cancer
... of triple-negative breast cancer Fanny Orlhac 1 , Olivier Humbert 2,3,4 , Thierry Pourcher 3,4 , Lun Jing 3,4 , Jean-Marie Guigonis 3,4 , Jacques Darcourt 2,3,4 , Nicholas Ayache 1 , Charles ... Voir le document complet
2
Helicase-like transcription factor expression is associated with a poor prognosis in Non-Small-Cell Lung Cancer (NSCLC)
... far to our knowledge, our study is the first to assess the clinical impact of WT and variant forms of HLTF expression in patients with ...TCGA in silico analysis of HLTF alterations including ... Voir le document complet
11
en fr Characterization of a sphingolipid signature of immune escape in triple negative breast cancer Caractérisation d’une signature sphingolipidique d’immunoéchappement dans le cancer du sein triple négatif
... Le cancer du sein est le cancer féminin le plus fréquent et celui qui cause le plus de décès dans le ...de cancer du sein qui diffèrent par l’expression des récepteurs aux œstrogènes, à la ... Voir le document complet
151
Co-targeting EGFR and mTOR with gefitinib and everolimus in triple-negative breast cancer cells
... pathways. To assess the effects of gefitinib and everoli- mus on the PI3K/AKT/mTOR and RAS/MAPK signalling pathways, we analysed the protein expressions of total and phosphorylated forms of ERK, AKT, mTOR, P70S6K ... Voir le document complet
13
Microbial markers in colorectal cancer detection and/or prognosis
... Colorectal cancer (CRC) is the second leading cause of cancer ...still associated with a poor prognosis among patients with advanced ...due to its slow progression from ... Voir le document complet
24
Role of stable free radicals in conjugated antioxidant and cytotoxicity treatment of triple negative breast cancer
... known to be involved in many breast cancers, including triple negative breast cancer ...TNBC are breast cancers that do not have receptors for estrogen (ER), ... Voir le document complet
22
Sujets connexes